DOJ probes UnitedHealth's Medicare billing practices, WSJ reports; shares tumble

Published On Feb 21, 2025, 8:06 AM

The U.S. Department of Justice (DOJ) is investigating UnitedHealth's Medicare billing practices, particularly in how it records diagnoses to receive additional payments for its Medicare Advantage plans. This news has caused a nearly 10% drop in UnitedHealth shares in premarket trading, which reflects concerns not only about the investigation but also about potential impacts on the company's financial performance. The DOJ's scrutiny comes amid ongoing challenges for UnitedHealth, including previous lawsuits and a cyberattack affecting its tech division.

Stock Forecasts

UNH

Negative

The ongoing investigation may lead to regulatory penalties, which could adversely affect UnitedHealth's revenue and profitability. The significant drop in share value indicates investor concern over potential long-term implications of the investigation and ongoing litigation. Furthermore, the healthcare sector is experiencing increased scrutiny overall, which may affect sentiment around healthcare stocks including UnitedHealth’s peers.

Related News

Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade-offs.

The company's former chief executive Brian Thompson was shot and killed in December.

UnitedHealth Group named Tim Noel the new CEO of the company's insurance division, UnitedHealthcare, after the targeted killing of former CEO Brian Thompson.